AEGLEA - Trademark Details
Status: 688 - Notice Of Allowance - Issued
Serial Number
90138790
Word Mark
AEGLEA
Status
688 - Notice Of Allowance - Issued
Status Date
2021-11-02
Filing Date
2020-08-26
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-09-07
Attorney Name
Law Office Assigned Location Code
L80
Employee Name
FIONDA, LAURA ELIZABET
Statements
Goods and Services
Pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; pharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of cancer; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of cancer; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of cancer; enzyme replacement therapy preparations for medical purposes; pharmaceutical preparations for the prevention and treatment of infectious diseases and immunological diseases; biopharmaceutical preparations for the prevention and treatment of infectious diseases and immunological diseases; pharmaceutical preparations for the treatment of homocystinuria; biopharmaceutical preparations for the treatment of homocystinuria; biotherapeutic preparations for the treatment of homocystinuria
Goods and Services
Scientific research in the fields of pharmaceuticals, biopharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, enzyme replacement therapeutics, and therapeutics, all for the treatment of rare genetic diseases, Arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; medical and scientific research in the field of pharmaceutical and biopharmaceutical treatment of rare genetic diseases, Arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; providing medical and scientific research information, consultancy, and advisory services, all in the fields of pharmaceuticals, biopharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, enzyme replacement therapeutics, and therapeutics treatments, and all for the treatment of rare genetic diseases, Arginase 1 deficiency, cancer, immunological diseases, homocystinuria, and infectious diseases; Design, engineering, research, development and testing services, all for medical research purposes in the fields of cancer, rare genetic disease, Arginase 1 deficiency treatments, immunological diseases, homocystinuria, and infectious diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-09-29
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-09-29
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Christopher M. Kindel
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0109780
Original Filing Date USPTO
2021-06-08
International Registration Number
1606874
International Registration Date
2021-06-08
International Status Code
480
International Renewal Date
2031-06-08
| Madrid History Events | ||
| Date | Code | Description |
| 2021-06-08 | ACERT | AUTOMATICALLY CERTIFIED |
| 2021-06-08 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2021-06-08 | APPST | IR CERTIFIED AND SENT TO IB |
| 2021-08-13 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
Trademark Events
| Event Date | Event Description |
| 2020-08-29 | NEW APPLICATION ENTERED IN TRAM |
| 2020-09-29 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-12-24 | ASSIGNED TO EXAMINER |
| 2020-12-31 | NON-FINAL ACTION WRITTEN |
| 2020-12-31 | NON-FINAL ACTION E-MAILED |
| 2020-12-31 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-06-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-06-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-06-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-07-31 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-08-18 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-09-07 | PUBLISHED FOR OPPOSITION |
| 2021-09-07 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-11-02 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
